Thomas Patrick Joyce, Jr. net worth and biography

Thomas Joyce, Jr. Biography and Net Worth

Thomas Joyce is President and Chief Executive Officer of Danaher Corporation, a position he assumed in September 2014. Thomas is responsible for the company’s strategic vision and leads the development and growth of Danaher’s global science and technology portfolio.

Thomas has more than 20 years of Danaher leadership experience. Prior to hisappointment as President and Chief Executive Officer, he served as Executive Vice President of Danaher Corporation, responsible for Danaher’s Water Quality platform and Life Sciences & Diagnostics segment.
In this role, Thomas increased Danaher’s Water Quality revenue by over $1.5 billion and led the company’s major acquisitions of Beckman Coulter and AB SCIEX. Throughout his tenure, Thomas has also played a key role in developing and evolving the Danaher Business System, Danaher’s common operating philosophy.

Thomas began his Danaher career in 1989 as a Project Manager in the Danaher Tool Group, and later transitioned into a manufacturing role. In 1995, Thomas became President of Delta Consolidated Industries. Following this assignment, he became President of Hach Company, the world leader in analytical instrumentation for drinking water and wastewater applications in 2001. In 2002, Thomas became a Group Executive and Corporate Officer with Danaher Corporation, which led to his transition to Executive Vice President in 2006.

Prior to joining Danaher, Thomas worked as a management consultant at Anderson Consulting, where he worked with a large number of manufacturing businesses to implement lean tools and optimize transactional processes.

Thomas was born and raised on the north shore of Chicago and earned his bachelor’s degree in Economics from the College of the Holy Cross in 1982. He and his wife, Claire, live in Washington, D.C. and have four children.

What is Thomas Patrick Joyce, Jr.'s net worth?: The estimated net worth of Thomas Patrick Joyce, Jr. is at least $71.51 million as of July 24th, 2020. Mr. Joyce, Jr. owns 285,569 shares of Danaher stock worth more than $71,509,333 as of April 24th. This net worth evaluation does not reflect any other assets that Mr. Joyce, Jr. may own. Learn More about Thomas Patrick Joyce, Jr.'s net worth.
How do I contact Thomas Patrick Joyce, Jr.?: The corporate mailing address for Mr. Joyce, Jr. and other Danaher executives is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. Danaher can also be reached via phone at (202) 828-0850 and via email at [email protected]. Learn More on Thomas Patrick Joyce, Jr.'s contact information.
Has Thomas Patrick Joyce, Jr. been buying or selling shares of Danaher?: Thomas Patrick Joyce, Jr. has not been actively trading shares of Danaher within the last three months. Most recently, Thomas Patrick Joyce, Jr. sold 181,394 shares of the business's stock in a transaction on Friday, July 24th. The shares were sold at an average price of $193.98, for a transaction totalling $35,186,808.12. Following the completion of the sale, the chief executive officer now directly owns 285,569 shares of the company's stock, valued at $55,394,674.62. Learn More on Thomas Patrick Joyce, Jr.'s trading history.
Who are Danaher's active insiders?: Danaher's insider roster includes Rainer Blair (EVP), Daniel Comas (EVP), Georgeann Couchara (SVP), William Daniel (EVP), Brian Ellis (SVP), Linda Filler (Director), Jose-Carlos Gutierrez-Ramos (SVP), Linda Hefner (Director), Jennifer Honeycutt (EVP), Thomas Joyce, Jr. (CEO), William King (SVP), Angela Lalor (SVP), Angela Lalor (SVP), Teri List (Director), Walter Lohr (Director), Robert Lutz (CAO), Matthew McGrew (CFO), Mitchell Rales (Chairman), Daniel Raskas (SVP), John Schwieters (Director), Alan Spoon (Director), Raymond Stevens (Director), Joakim Weidemanis (EVP), and Elias Zerhouni (Director). Learn More on Danaher's active insiders.
Are insiders buying or selling shares of Danaher?: In the last twelve months, insiders at the conglomerate sold shares 14 times. They sold a total of 115,345 shares worth more than $28,921,815.03. The most recent insider tranaction occured on February, 26th when SVP Daniel Raskas sold 23,757 shares worth more than $5,986,764.00. Insiders at Danaher own 10.9% of the company. Learn More about insider trades at Danaher.
Information on this page was last updated on 2/26/2024.

Thomas Patrick Joyce, Jr. Insider Trading History at Danaher

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/24/2020	Sell	181,394	$193.98	$35,186,808.12	285,569
2/7/2020	Sell	20,492	$162.03	$3,320,318.76	157,694
1/31/2020	Sell	132,474	$162.51	$21,528,349.74	246,027
7/19/2019	Sell	70,544	$141.77	$10,001,022.88	271,023
5/16/2019	Sell	14,454	$132.79	$1,919,346.66	200,479
4/29/2019	Sell	183,878	$131.30	$24,143,181.40	302,377
2/24/2019	Sell	3,082	$131.84	$406,330.88	302,377
11/7/2018	Sell	5,212	$103.89	$541,474.68	151,829
7/31/2018	Sell	104,913	$101.88	$10,688,536.44	276,438
4/20/2018	Sell	120,354	$101.17	$12,176,214.18	151,959
11/1/2017	Sell	125,989	$92.64	$11,671,620.96	271,737
7/31/2017	Sell	9,772	$81.78	$799,154.16	155,520
4/21/2017	Sell	54,006	$82.52	$4,456,575.12	142,157
10/21/2016	Sell	36,125	$79.68	$2,878,440.00	205,407
8/1/2016	Sell	45,897	$81.44	$3,737,851.68	179,054
4/22/2016	Sell	14,630	$95.50	$1,397,165.00	137,246
1/27/2016	Sell	25,300	$83.98	$2,124,694.00	115,823
10/23/2015	Sell	25,300	$93.47	$2,364,791.00	115,823
7/24/2015	Sell	25,300	$88.20	$2,231,460.00
4/24/2015	Sell	43,945	$83.81	$3,683,030.45
11/3/2014	Sell	50,000	$79.97	$3,998,500.00
8/6/2013	Sell	48,000	$67.04	$3,217,920.00	124,211
2/25/2013	Sell	20,723	$61.24	$1,269,076.52

Thomas Patrick Joyce, Jr. Buying and Selling Activity at Danaher

Danaher Company Overview

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Today's Range

Now: $250.41

$247.98

$254.09

50 Day Range

MA: $248.95

$235.37

$256.19

2 Week Range

Now: $250.41

$182.09

$259.00

Volume

3,064,441 shs

Average Volume

2,783,958 shs

Market Capitalization

$185.44 billion

P/E Ratio

39.19

Dividend Yield

0.46%

Beta

0.83

Biden replacement revealed?

From Paradigm Press | Ad

A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.

See his shocking evidence in this new report